Who is the CEO of Opus Genetics?

Dr. George Magrath, MD, MBA, MS, serves as the Chief Executive Officer and a member of the Board of Directors.

How many employees does Opus Genetics have?

Opus Genetics has approximately 18 total employees.

Where is Opus Genetics headquartered?

The company is headquartered at 8 Davis Drive, Suite 220, Durham, NC 27713.

What industry is Opus Genetics in?

Opus Genetics operates in Drug Discovery / Biopharmaceutical.

When was Opus Genetics founded?

Opus Genetics was founded in 2018.

Is Opus Genetics still active?

Yes, Opus Genetics was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.

How do I sell to Opus Genetics?

Research Opus Genetics's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details.

Data Surfer

How it works Insights Pricing FAQ Contact Login

Opus Genetics

Drug Discovery / Biopharmaceutical

Durham, USA

27 employees

Founded 2018

opusgtx.com

Verified active February 2, 2026

Key Highlights

CEO: George Magrath
Headquarters: Durham
Founded: 2018
Employees: 18
Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company focused on developing and com

About Opus Genetics

Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company committed to building innovative, efficient, and sustainable gene therapies for the treatment of inherited retinal diseases (IRDs) and other retinal and refractive disorders.

Leadership Team

George Magrath

Chief Executive Officer

Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.

Company Facts

Ownership Public Company

Stock IRD (Nasdaq)

Funding Public

Parent Company Ocuphire Pharma

Technology Stack

Gene therapy

Office Locations

Farmington Hills, MI

Why Contact Opus Genetics?

Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing gene therapies for Inherited Retinal Diseases (IRDs) and other retinal and refractive d

Who Should Contact Opus Genetics for Business?

Clinical-stage biopharmaceutical development and commercialization of gene therapies.

Similar Companies

Companies that compete with or operate in similar markets to Opus Genetics:

IQVIA Holdings
BioCryst Pharmaceuticals

Frequently Asked Questions

Who is the CEO of Opus Genetics?: Dr. George Magrath, MD, MBA, MS, serves as the Chief Executive Officer and a member of the Board of Directors.
What does Opus Genetics do?: Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing gene therapies for Inherited Retinal Diseases (IRDs) and other retinal and refractive disorders.
How many employees does Opus Genetics have?: Opus Genetics has approximately 18 total employees.
Where is Opus Genetics headquartered?: The company is headquartered at 8 Davis Drive, Suite 220, Durham, NC 27713.
What industry is Opus Genetics in?: Opus Genetics operates in Drug Discovery / Biopharmaceutical.
When was Opus Genetics founded?: Opus Genetics was founded in 2018.
Is Opus Genetics still active?: Yes, Opus Genetics was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to Opus Genetics?: Research Opus Genetics's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.